Showing results (381-390 of 444) with videos related to

Sort By:
Pageof 45
Respiratory Research|November 1, 2022
Predicting the risk of chest radiograph abnormality 12-weeks post hospitalisation with SARS CoV-2 PCR confirmed COVID-19Tim Jm Wallis, Benjamin Welham, Alex Kong, et al.
Pulmonary Pharmacology & Therapeutics|July 2, 2017
Individualizing duration of antibiotic therapy in community-acquired pneumoniaStefano Aliberti, Julio Ramirez, Fabio Giuliani, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2016
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and ChildrenDavid M Lewinsohn, Michael K Leonard, Philip A LoBue, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M Maher, Shervin Assassi, Arata Azuma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2017
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and ChildrenDavid M Lewinsohn, Michael K Leonard, Philip A LoBue, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Individualised Exercise Training Enhances Antioxidant Buffering Capacity in Idiopathic Pulmonary FibrosisTim J M Wallis, Magdalena Minnion, Anna Freeman, et al.
Pageof 45